Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Evaluation of The Absolute Bioavailability of TH104

NCT06198686 is registered in ClinicalTrials.gov with Tharimmune Inc as lead sponsor.

NCT NCT06198686
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06198686 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Evaluation of The Absolute Bioavailability of TH104
Lead sponsor
Tharimmune Inc
Phase
Phase 1
Overall status
Completed
Start date
January 26, 2024
Completion date
November 6, 2024
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy